Triple tetracycline (Deteclo) in the treatment of chlamydial infection of the female genital tract.
The efficacy of treating genital Chlamydia in women using Deteclo 300 mg twice daily for seven and 21 days has been studied. Forty-four patients were treated for seven days and 20 for 21 days. Seven days of treatment was as effective in eliminating Chlamydia trachomatis from the female genital tract as 21 days. The reproducibility of the technique of isolation of C. trachomatis was assessed by delaying treatment in 10 patients for up to 156 days and find C. trachomatis still present.
D002690:Chlamydia Infections / Q000188:drug therapy*; D002692:Chlamydia trachomatis / Q000302:isolation & purification; D002751:Chlortetracycline / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003707:Demeclocycline / Q000627:therapeutic use; D004338:Drug Combinations; D005260:Female; D006801:Humans; D013754:Tetracyclines / Q000627:therapeutic use*; D014552:Urinary Tract Infections / Q000188:drug therapy*
D004338:Drug Combinations; D013754:Tetracyclines; D003707:Demeclocycline; D002751:Chlortetracycline